Cannabix Targets Combat Sports with Marijuana Breath Test Rollout

  • Cannabix Technologies Inc. will present its Marijuana Breath Test (MBT) at the ABC Boxing & MMA Conference in Orlando, Florida, August 2026.
  • The MBT aims to provide objective, non-invasive recent-use THC detection for combat sports regulators and promoters.
  • Omega Laboratories will support Cannabix with forensic drug testing expertise and laboratory confirmation capabilities.
  • Cannabix is also developing a broader 5-panel breath testing platform for multiple drug classes.

Cannabix is targeting the combat sports market with its Marijuana Breath Test, aiming to provide a more practical and relevant tool for cannabis-related decisions in safety-sensitive settings. The technology addresses the challenge of balancing athlete rights, public safety, and competitive integrity as cannabis regulations evolve. This move aligns with broader industry trends towards non-invasive, time-relevant drug testing solutions.

Market Adoption
Whether combat sports regulators will embrace recent-use breath testing over traditional specimen testing.
Regulatory Shifts
How evolving cannabis laws across North America and internationally impact the demand for Cannabix's technology.
Technological Expansion
The pace at which Cannabix can develop and commercialize its broader 5-panel breath testing platform.